Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 2 8Phase 2/3 4Phase 3 3Phase 4 2Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 117Neoplasms 101Prostatic Neoplasms 76Carcinoma, Non-Small-Cell Lung 75Colorectal Neoplasms 73Carcinoma, Hepatocellular 67Leukemia, Myeloid, Acute 58Stomach Neoplasms 52Neoplasm Metastasis 50Lung Neoplasms 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Pancreatic Neoplasms 40Recurrence 36Head and Neck Neoplasms 32Rectal Neoplasms 30Colonic Neoplasms 30Leukemia 29Multiple Myeloma 28Ovarian Neoplasms 26Lymphoma 25Squamous Cell Carcinoma of Head and Neck 24Hematologic Neoplasms 23Melanoma 22Urinary Bladder Neoplasms 20Liver Neoplasms 20Polycystic Ovary Syndrome 19Myelodysplastic Syndromes 19Lymphoma, Large B-Cell, Diffuse 19Esophageal Neoplasms 19Uterine Cervical Neoplasms 16

Interventions

Propranolol 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × Hemangioma, Capillary × Clear all
NCT06798363 2026-03-16

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

West China Hospital

Phase 2/3 Recruiting
40 enrolled

Ulcer, Hemangioma, Capillary

NCT06677853 2024-11-07

Timolol Maleate Gel for the Treatment of Infantile Hemangioma

Auson Pharmaceuticals Inc.

Phase 2/3 Completed
168 enrolled

Hemangioma, Capillary

NCT01056341 2015-12-10

Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy

Pierre Fabre Dermatology

Phase 2/3 Completed
512 enrolled 13 charts

Hemangioma, Capillary

NCT00744185 2012-07-19

HEMANGIOMA

University Hospital, Bordeaux

Phase 2/3 Terminated
14 enrolled

Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡